Total Funding
72
74
Total FundingPrivate Equity raised
Growth Score
-14 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
796
Caris Life Sciences develops molecular profiling and AI-driven technologies to support precision medicine in oncology.
- Mike Weinstein: EVP & Chief Financial Officer
- Thomas Parker: Senior Vice President & Chief Financial Officer
About the Company
Caris Life Sciences develops molecular profiling and AI-driven technologies to support precision medicine in oncology. The company offers a comprehensive tumor profiling service known as Caris Molecular Intelligence, which analyzes DNA, RNA, and proteins to help oncologists identify potential treatment options. Caris also operates a platform called
Caris CODEai that integrates molecular data with clinical outcomes to support research and drug development. Its services cater to biopharma partners, healthcare providers, and academic institutions aiming to improve cancer diagnostics and therapy selection. The company incorporates machine learning models to discover new biomarkers and therapeutic targets based on large-scale multi-omic data.
